Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
RESEARCH TOOLSreports
Holding MDGL?
Track your performance easily
Madrigal Pharmaceuticals (MDGL) Ownership Overview
19.56% Insiders
27.43% Mutual Funds
0.07% Other Institutional Investors
14.90% ETFs
38.03% Public Companies and Individual Investors
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 42.41% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 38.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 27, 2025 | xxxxxxxxxxxxx | $116328 | |
| Jan 27, 2025 | William John Sibold President & Ceo,director | xxxxxxxxxxxxx | $531020 |
| Jan 27, 2025 | Rebecca Taub Pres., R&d, And Cmo,director | xxxxxxxxxxxxx | $217236 |
| Jan 27, 2025 | Robert E. Waltermire Svp, Chief Pharma Dev | xxxxxxxxxxxxx | $34530 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $8092585 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $31215439 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $433353240 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,042,000 | Institution | 9.36% | 560,345,220 | |
| 1,974,590 | Institution | 9.05% | 541,847,242 | |
| 1,794,831 | Insider | 8.23% | 492,519,575 | |
| 1,756,449 | Institution | 8.05% | 481,987,170 | |
| 1,608,624 | Institution | 7.38% | 441,422,512 | |
| 1,583,921 | Institution | 7.26% | 434,643,762 | |
| 1,114,539 | Insider | 5.11% | 305,840,647 | |
| 841,989 | Insider | 3.86% | 231,050,201 | |
| 828,316 | Institution | 3.80% | 227,298,194 | |
| 404,303 | Institution | 1.85% | 110,944,786 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,608,624 | Institution | 7.38% | 441,422,512 | |
| 1,583,921 | Institution | 7.26% | 434,643,762 | |
| 272,634 | Institution | 1.25% | 74,813,496 | |
| 219,753 | Institution | 1.01% | 60,302,421 | |
| 211,019 | Institution | 0.97% | 57,905,724 | |
| 198,711 | Institution | 0.91% | 54,528,286 | |
| 197,860 | Institution | 0.91% | 54,294,763 | |
| 191,446 | Institution | 0.88% | 52,534,697 | |
| 112,700 | Institution | 0.52% | 30,926,007 | |
| 111,424 | Institution | 0.51% | 30,575,860 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 573,653 | Institution | 2.63% | 188,267,178 | |
| 478,274 | Institution | 2.19% | 131,243,168 | |
| 465,539 | Institution | 2.13% | 152,785,244 | |
| 369,437 | Institution | 1.69% | 101,270,070 | |
| 314,772 | Institution | 1.44% | 103,305,023 | |
| 253,819 | Institution | 1.16% | 83,300,858 | |
| 164,668 | Institution | 0.75% | 45,186,546 | |
| 117,340 | Institution | 0.54% | 32,199,269 | |
| 82,506 | Institution | 0.38% | 27,077,644 | |
| 82,463 | Institution | 0.38% | 22,604,758 |
FAQ
Who Owns Madrigal Pharmaceuticals Inc (MDGL)?
According to the latest TipRanks data, approximately 0.07% of the company's stock is held by institutional investors, 19.56% is held by insiders, and 38.03% is held by retail investors.
What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.07% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors.
What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.03% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors.
Who owns the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
John Paulson owns the most shares of Madrigal Pharmaceuticals Inc (MDGL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.